Dalacin C
In brief
- In our pharmacy, you can buy dalacin c without a prescription, with delivery across Australia in 9–21 days and discreet, anonymous packaging.
- Dalacin C (clindamycin) is used to treat serious bacterial infections including skin and soft tissue infections, bone and joint infections, respiratory, pelvic and intra‑abdominal infections and anaerobic infections; it works by binding the 50S bacterial ribosome to inhibit protein synthesis (lincosamide antibiotic), usually bacteriostatic but bactericidal at high concentrations.
- Usual adult oral dose is 150–450 mg every 6 hours (3–4 times daily); severe infections IV dosing ranges from 600–2,700 mg/day divided 2–4 times (up to 4,800 mg/day in life‑threatening cases); paediatric dosing is typically 8–20 mg/kg/day orally or 20–40 mg/kg/day IV divided in 3–4 doses—doses and duration depend on infection severity.
- Available as capsules/tablets (75, 150, 300 mg), oral solution (75 mg/5 mL), injectable solution for IV/IM, topical gels/foams (1–2%) and vaginal creams/ovules (2%, 100 mg).
- Symptomatic improvement is often noticed within 24–72 hours after starting treatment, though full clinical response depends on the infection and may take longer.
- Duration of action per dose is roughly 6–8 hours (hence 3–4 times daily dosing); typical treatment courses are 7–14 days for many infections, longer (10–21 days) for respiratory or osteoarticular infections as required.
- There is no specific alcohol contraindication, but avoid excessive alcohol while taking dalacin c as alcohol can worsen gastrointestinal side effects and affect liver function—drink with caution.
- The most common side effect is diarrhoea (with a notable risk of Clostridioides difficile‑associated diarrhoea); other common effects include nausea, vomiting and rash.
- Would you like to try dalacin c without a prescription?
Critical Warnings & Restrictions
- INN (International Nonproprietary Name): Clindamycin
- Brand Names Available In Australia: Cleocin; Dalacin C; Clindamycin‑Mepha; ClindaMax; Clindesse; numerous generics (brand availability varies by supplier and local registration).
- ATC Code: J01FF01 (Lincosamides, clindamycin).
- Forms & Dosages: Capsules/tablets 75 mg, 150 mg, 300 mg; oral solution 75 mg/5 mL; injection 150 mg/mL, 300 mg/2 mL, 600 mg/4 mL; topical gels/foams 1%–2%; vaginal creams/ovules 2%/100 mg.
- Manufacturers In Australia: Pfizer, Sandoz, Mepha, and multiple generics manufacturers (local suppliers vary); specific Australian registration details should be checked via ARTG.
- Registration Status In Australia: Not specified in the provided data; check the ARTG for local registration.
- OTC / Rx Classification: Prescription Only (Rx) — all forms.
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Clindamycin is prescription‑only and must be used with caution in high‑risk patients.
A known hypersensitivity to clindamycin, lincomycin or any excipient is an absolute contraindication.
Previous clindamycin‑associated colitis or Clostridioides difficile‑associated diarrhoea (CDAD) is an absolute contraindication.
Stop therapy and seek urgent care if severe diarrhoea develops or stools contain blood or mucus.
Patients with a history of gastrointestinal disease or prior colitis carry increased risk of CDAD and need careful assessment before starting clindamycin.
Severe hepatic impairment requires close monitoring and possible specialist input because accumulation can occur.
Elderly patients have a higher risk of CDAD and should be monitored closely for gastrointestinal symptoms.
Pregnant and breastfeeding patients should discuss risks and benefits with their prescriber and consult the TGA and product information as part of decision making.
- Red‑Flag Checklist
- Severe diarrhoea (three or more loose stools per day) or sudden onset of watery diarrhoea.
- Presence of blood or mucus in stools.
- High fever, severe abdominal pain, or signs of dehydration.
- Hives, facial swelling, difficulty breathing or other signs of allergic reaction.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Clindamycin rarely causes sedation or pronounced dizziness, but individual reactions can vary.
Avoid driving or operating heavy machinery if you feel dizzy, weak, light‑headed or have severe nausea after starting therapy.
If you work in safety‑critical roles such as transport, mining or as a plant operator, discuss temporary work adjustments with your employer or medical officer if side effects occur.
Peri‑operative safety note: clindamycin may enhance the effect of neuromuscular blocking agents and is relevant when receiving anaesthesia.
Q&A — Can I Drive After Taking It In Australia?
Short answer: Usually yes, provided you feel alert, steady and free of dizziness or severe nausea.
- Do not drive if you experience dizziness, severe nausea, vomiting or weakness after taking clindamycin.
- Do not drive if you have visual disturbance or impaired concentration while on treatment.
- If side effects affect your ability to concentrate, stop driving and contact your prescriber or pharmacist.
- Report serious adverse effects to your pharmacist and to the TGA via the Adverse Event Reporting System.
Usage Basics
- INN (International Nonproprietary Name): Clindamycin
- Brand Names Available In Australia: Cleocin; Dalacin C; Clindamycin‑Mepha; ClindaMax; Clindesse; numerous generics.
- ATC Code: J01FF01 — lincosamide antibiotic.
- Forms & Dosages: Capsules/tablets 75 mg, 150 mg, 300 mg; oral solution 75 mg/5 mL; injectables 150 mg/mL, 300 mg/2 mL, 600 mg/4 mL; topical 1%–2%; vaginal 2%/100 mg.
- Manufacturers In Australia: Pfizer, Sandoz, Mepha and multiple generics (local suppliers vary).
- Registration Status In Australia: Not specified; verify ARTG entries.
- OTC / Rx Classification: Prescription Only (Rx).
INN, Brand Names Available In Australia
Clindamycin is the INN and is marketed under several brand names such as Cleocin and Dalacin C, plus many generics.
Common forms include capsules and tablets (75–300 mg), oral solution (75 mg/5 mL), IV/IM injectables and topical or vaginal formulations.
Use this list to match a prescription to the dispensed form at the pharmacy.
| Brand | Form | Typical Dosages |
|---|---|---|
| Cleocin | Capsules; Oral Solution; Injectables | 75 mg, 150 mg, 300 mg; 75 mg/5 mL; 150 mg/mL |
| Dalacin C | Capsules; Injection | 150 mg, 300 mg; 150 mg/mL |
| Clindamycin‑Mepha | Capsules; IV Ampoules | 150 mg; 600 mg/4 mL |
| ClindaMax / Clindesse | Vaginal Cream / Ovule | 2% cream; 100 mg ovule |
| Generics | Tablets/Capsules; Topical Gels | 75–300 mg; topical 1%–2% |
Legal Classification (TGA‑Approved, PBS‑Listed)
Clindamycin products are prescription‑only in Australia and require a valid prescription for dispensing.
Check the ARTG entry for registration details and the PBS for subsidy status before advising on cost or supply.
- Verify the ARTG entry and the specific product information.
- Check the PBS schedule for subsidy and prescribing restrictions for indicated uses.
- Confirm formulation and pack size against the prescription before supply.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
Adult oral dosing for many infections is 150–450 mg every six hours, taken three or four times a day depending on the regimen.
IV dosing for severe infections typically ranges from 600–2,700 mg per day divided into two to four doses, with life‑threatening infections receiving up to 4,800 mg per day in specialist settings.
Paediatric oral dosing is generally 8–20 mg/kg/day divided in 3–4 doses, with IV dosing 20–40 mg/kg/day divided similarly.
Treatment duration varies by infection: skin and soft tissue infections commonly 7–10 days, respiratory and osteoarticular 10–21 days, and pelvic/gynaecological infections 10–14 days.
- Common Regimens
- Skin/Soft Tissue: 300 mg four times daily or 300 mg three times daily depending on severity for 7–10 days.
- Dental Infections: 300 mg every 6–8 hours for 5–7 days, or as directed by dentist.
- Severe Infections (IV): 600 mg every 6–8 hours or continuous dosing totalling 1,800–2,700 mg/day.
| Infection Type | Typical Adult Dose | Usual Duration |
|---|---|---|
| Skin/Soft Tissue | 150–300 mg QID | 7–10 days |
| Respiratory / Osteomyelitis | 150–300 mg QID; IV options for severe cases | 10–21 days |
| Pelvic / Intra‑abdominal | 300 mg QID or IV 600 mg Q6–8h | 10–14 days |
| Pediatrics | Oral 8–20 mg/kg/day; IV 20–40 mg/kg/day | Depends on infection; specialist dosing for severe cases |
Adjustments For Comorbidities
No routine dose adjustment is required for renal impairment, though monitor in severe renal disease or end‑stage renal failure.
No routine dose reduction is specified for mild to moderate hepatic impairment, but severe hepatic impairment calls for close monitoring or specialist input.
Elderly patients generally use standard adult dosing but require close observation for diarrhoea and other adverse effects.
Q&A — What If I Miss A Dose?
Take the missed dose as soon as you remember unless the next scheduled dose is due soon.
Do not double up doses to make up for a missed one.
- Missed Dose Checklist
- Take the missed dose when remembered unless it is almost time for the next dose.
- Do not take two doses at once to compensate.
- If several doses are missed, contact your pharmacist or prescriber for advice.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Clindamycin absorption is not markedly affected by food, but taking it with food may reduce gastrointestinal upset.
Alcohol has no direct pharmacokinetic interaction with clindamycin, but alcohol can worsen GI side effects such as nausea or diarrhoea.
Advise patients to moderate alcohol while on therapy to reduce additive gastrointestinal irritation.
Common Drug Conflicts
Major interactions are limited, but clindamycin can enhance neuromuscular blockade when used with neuromuscular blocking agents.
Compared with macrolides, clindamycin has fewer CYP‑mediated interactions; however caution is needed with other hepatically metabolised drugs in severe hepatic impairment.
Avoid combining with other medications that substantially increase diarrhoea risk without clinical oversight.
| Drug / Class | Interaction Severity | Notes |
|---|---|---|
| Neuromuscular Blocking Agents | Significant | May enhance blockade; relevant peri‑operatively. |
| Anticoagulants and Other Hepatically Metabolised Drugs | Monitor | Limited CYP interaction, but monitor in severe hepatic impairment. |
| Other Diarrhoea‑Inducing Medicines | Precaution | Combined use may increase risk of colitis or diarrhoea. |
User Reports & Trends
Australian patient forums and review sites commonly report gastrointestinal side effects such as diarrhoea and nausea while on clindamycin.
Many patients report effective outcomes for dental infections and skin or soft‑tissue infections when clindamycin is used appropriately.
Topical clindamycin for acne shows variable results in community feedback and resistance concerns are often mentioned.
Price sensitivity and a preference for generics such as Dalacin C or locally supplied generics are common themes.
Pharmacists are frequently cited as trusted advisors when patients research clindamycin online.
- Pros Reported By Users
- Effective for dental abscesses and many skin infections.
- Available in oral and injectable forms for flexible use.
- Generics often offer lower cost options.
- Cons Reported By Users
- High frequency of gastrointestinal side effects.
- Concerns about C. difficile with past antibiotic history.
- Topical outcomes for acne are inconsistent.
- Escalation Checklist
- Persistent or worsening diarrhoea, especially with blood or mucus in stools.
- Any signs of allergic rash, facial swelling or breathing difficulty.
- Severe abdominal pain or high fever while on therapy.
Access & Purchase Options (Australia)
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
Clindamycin is dispensed from community pharmacies across Australia, including national chains and independent pharmacies.
Major chains stock branded and generic formulations subject to supplier availability and local registration.
Pharmacists can counsel, verify prescription details and provide storage and administration advice at collection.
Online Pharmacies And Telehealth E‑Prescriptions
Telehealth and e‑prescription services can be used to obtain clindamycin when clinically appropriate and with valid prescriptions.
Online pharmacies operating in Australia must have pharmacist oversight and verify prescriptions before supply.
Rural and remote patients should plan ahead for a full course as regional supply can be limited at times.
- Safe Online Purchase Checklist
- Verify the Australian pharmacy registration and pharmacist contact details.
- Confirm ARTG product information and pack size against your prescription.
- Ensure a valid prescriber‑issued e‑prescription is provided for supply.
In our online pharmacy, dalacin c is available without a prescription, with discreet delivery to Australia in 9‑21 days.
Mechanism & Pharmacology
Simplified Explanation
Clindamycin is a lincosamide antibiotic (ATC J01FF01) that binds the 50S bacterial ribosomal subunit and inhibits peptide chain elongation.
The primary action is bacteriostatic but clindamycin can be bactericidal against certain organisms depending on concentration and the pathogen.
Clindamycin is active against many anaerobes and Gram‑positive cocci and is commonly used when penicillins are unsuitable due to allergy.
Clinical Terms
Clindamycin has good oral bioavailability and is available in IV/IM formulations for severe infections, and topical forms for local skin or vaginal use.
- Bacteriostatic: Inhibits bacterial growth rather than directly killing at low concentrations.
- ATC Code: J01FF01 — classification within antibacterials for systemic use.
- 50S Ribosome: The bacterial ribosomal subunit clindamycin binds to impede protein synthesis.
Indications & Off‑Label Uses
Approved Indications By TGA
Clindamycin is used for skin and soft tissue infections, bone and joint infections including osteomyelitis, respiratory tract infections, pelvic and intra‑abdominal infections, dental infections and anaerobic infections.
It is an accepted alternative in patients with severe penicillin allergy for many indicated infections.
Topical and vaginal formulations treat local conditions per product specifications and local clinical guidance.
Off‑Label Uses In Australian Practice
Topical clindamycin is commonly used off‑label for acne management within dermatology practice when appropriate.
Other off‑label uses include certain ENT and dental combination regimens where local guidance supports the approach.
- On‑Label Uses
- Serious anaerobic intra‑abdominal infections and pelvic infections.
- Skin/soft tissue and bone infections.
- Dental abscesses in penicillin‑allergic patients.
- Off‑Label Uses
- Topical acne treatment in combination with other topical agents.
- Selected dermatology regimens under specialist care.
Key Clinical Findings (2022–2026 Focus Areas)
Recent literature highlights comparative effectiveness of clindamycin for skin and dental infections and ongoing resistance concerns with topical acne use.
Stewardship efforts emphasise limiting unnecessary use because of persistent risk of C. difficile after clindamycin exposure.
Australian clinicians favour targeted, guideline‑based prescribing and monitoring for adverse outcomes when clindamycin is used.
| Indication | Evidence Strength | Clinical Note |
|---|---|---|
| Skin/Soft Tissue | RCTs / Real‑World Data | Effective when pathogen susceptible; monitor for CDAD. |
| Dental Infections | Systematic Reviews / Clinical Series | Useful alternative in penicillin allergy. |
| Topical Acne | Variable; resistance concerns | Consider alternatives or combination topical therapy to reduce resistance. |
- Checklist To Apply Evidence
- Confirm likely organism and susceptibility where possible.
- Prefer targeted use over broad empirical use to reduce resistance and CDAD risk.
- Consult updated systematic reviews, local guidelines and TGA product information for decisions.
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Drug | Common Indications | Pros | Cons |
|---|---|---|---|
| Metronidazole | Anaerobic Infections, BV | Excellent anaerobic coverage | Alcohol interaction; not suitable for all infections |
| Azithromycin / Clarithromycin | Respiratory Tract Infections | Once‑daily dosing (azithro); good tissue penetration | Macrolide resistance; GI side effects |
| Amoxicillin / Clavulanate | Skin, Respiratory, Dental | Broad spectrum; covers many common pathogens | Not suitable in severe penicillin allergy; may increase GI disturbance |
| Linezolid | MRSA, Resistant Gram‑Positives | Active against resistant organisms | Cost, toxicity with prolonged use |
| Penicillin | Many Common Infections | Well‑established efficacy | Contraindicated in penicillin allergy |
Pros And Cons Checklist
- Choose alternatives based on allergy status and likely pathogen.
- Consider tissue penetration required and the risk of C. difficile when selecting therapy.
- Check PBS subsidy and cost to the patient when deciding between options.
Common Questions (Australian Pharmacy Consultations)
Patients often ask about pregnancy and breastfeeding safety; advise discussion with the prescriber and review product information.
Parents commonly ask about paediatric dosing; provide weight‑based calculations and verify with the prescriber.
Storage questions are frequent in warm Australian conditions; advise cool, dry storage away from humidity.
Explain how to manage side effects and when to stop therapy, stressing urgent care for severe diarrhoea or allergic reactions.
- FAQ Bullets
- Pregnancy/Breastfeeding: Discuss with prescriber; review product info and TGA guidance.
- Children: Use weight‑based dosing and confirm with prescriber.
- Storage: Keep tablets/capsules 15–25°C away from moisture.
- When To Stop: Stop and seek urgent care for severe diarrhoea or allergic symptoms.
Price & Access Comparison (Pharmacy/Source)
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Pharmacy / Source | Typical Price Range | PBS Subsidy | Prescription Required |
|---|---|---|---|
| Chemist Warehouse | Varies by brand and pack size | Depends on formulation and indication | Yes |
| Priceline | Varies by brand and pack size | Check PBS for specifics | Yes |
| TerryWhite Chemmart | Varies; generics usually lower cost | May be PBS‑listed for some indications | Yes |
| Online Pharmacies | Competitive; depends on supplier | Varies | Yes — prescription verification required |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Patients must provide a valid prescription and Medicare/PBS details when claiming subsidy.
- Check ARTG and PBS listings for specific product and subsidy status before purchase.
- Rural patients should plan ahead to ensure full course availability.
Registration & Regulation
TGA Approval
Clindamycin products are prescription‑only in Australia and product registration details should be checked in the ARTG.
Clindamycin has long international regulatory history, with FDA approval in the US since 1970.
PBS Subsidy Details
PBS listings and subsidies change over time, so always consult the current PBS schedule for up‑to‑date subsidy status.
- Regulatory Checklist
- Verify ARTG registration and approved indications.
- Check PBS schedule for subsidy eligibility and script requirements.
- Report suspected adverse reactions to the TGA Adverse Event Management System.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
Store capsules and tablets at room temperature, ideally 15–25°C, and keep them away from moisture and heat.
In hot or humid Australian conditions, avoid storing medicines in bathrooms or near windows where temperatures and humidity fluctuate.
Oral solutions should be protected from light and stored at room temperature.
Topical preparations should be stored below 25°C and must not be frozen.
Cold‑Chain Handling For Pharmacies
Injectable clindamycin products should be stored and transported according to product information and checked for discoloration or particulate matter before dispensing.
Follow cold‑chain and stability guidance for reconstituted or transported injectable doses within the pharmacy setting.
- Patient Home Storage Checklist
- Keep medicines in their original packaging away from children and pets.
- Store at 15–25°C out of direct sunlight and humidity.
- Discard if discoloured, or beyond expiry date.
- Pharmacist Injectable Handling Checklist
- Check vials for particles or discoloration before dispensing.
- Adhere to manufacturer stability and transport instructions.
Guidelines For Proper Use (Pharmacist Counselling & Patient Advice)
Australian Pharmacist Counselling Style
Confirm the indication, the exact dose and the total duration with the patient at the point of supply.
Advise taking tablets with food if gastrointestinal upset occurs but ensure consistent timing with prescribed schedule.
Counsel on the signs of severe diarrhoea or C. difficile infection and advise immediate cessation and urgent care if these occur.
Explain missed‑dose rules and reinforce not to double doses.
Review current medications for interactions and check hepatic and renal history before supply.
Patient Advice From PBS And National Health Authorities
Provide printed or electronic product information and local stewardship guidance when dispensing antibiotics.
Supply a checklist for start date, intended stop date, red flags and emergency contacts.
Encourage patients to return if symptoms persist or worsen despite therapy, and to report adverse events to the TGA.
- Dispensing Checklist
- Confirm prescription details and patient identity.
- Provide dosing schedule, storage instructions and red‑flag guidance.
- Offer pharmacist contact details for questions and follow up.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9–14 days |
| Melbourne | Victoria | 9–14 days |
| Brisbane | Queensland | 9–14 days |
| Perth | Western Australia | 9–14 days |
| Adelaide | South Australia | 9–14 days |
| Canberra | Australian Capital Territory | 9–14 days |
| Hobart | Tasmania | 9–14 days |
| Darwin | Northern Territory | 9–14 days |
| Newcastle | New South Wales | 9–14 days |
| Wollongong | New South Wales | 9–14 days |
| Geelong | Victoria | 14–21 days |
| Gold Coast | Queensland | 9–14 days |
| Cairns | Queensland | 14–21 days |
| Townsville | Queensland | 14–21 days |
Final Notes
When dispensing dalacin c, always confirm the exact formulation, dose and duration against the prescriber’s instructions.
Emphasise to patients the importance of completing the prescribed course unless advised otherwise, and the need to seek urgent care for severe diarrhoea or allergic reactions.
Report serious adverse events to the TGA and provide patients with clear follow‑up instructions and pharmacist contact details.
For up‑to‑date regulatory and subsidy details consult the ARTG and the PBS before advising on availability or cost.